The Early Psychosis Screener (EPS): Item development and qualitative validation
- PMID: 29254878
- PMCID: PMC6003837
- DOI: 10.1016/j.schres.2017.11.027
The Early Psychosis Screener (EPS): Item development and qualitative validation
Abstract
A panel of experts assembled and analyzed a comprehensive item bank from which a highly sensitive and specific early psychosis screener could be developed. Twenty well-established assessments relating to the prodromal stage, early psychosis, and psychosis were identified. Using DSM-5 criteria, we identified the core concepts represented by each of the items in each of the assessments. These granular core concepts were converted into a uniform set of 490 self-report items using a Likert scale and a 'past 30days' time frame. Partial redundancy was allowed to assure adequate concept coverage. A panel of experts and TeleSage staff rated these items and eliminated 189 items, resulting in 301 items. The items were subjected to five rounds of cognitive interviewing with 16 individuals at clinically high risk for psychosis and 26 community mental health center patients. After each round, the expert panel iteratively reviewed, rated, revised, added, or deleted items to maximize clarity and centrality to the concept. As a result of the interviews, 36 items were revised, 52 items were added, and 205 items were deleted. By the last round of cognitive interviewing, all of the items were clearly understood by all participants. In future work, responses to the final set of 148 items and machine learning techniques will be used to quantitatively identify the subset of items that will best predict clinical high-risk status and conversion.
Keywords: CAARMS; NAPLS; PQ-B; Prodromal; Psychosis;; SIPS; Schizophrenia; Screener.
Copyright © 2017 Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of Interest
Drs. Inger and Benjamin Brodey are the sole owners of TeleSage, Inc. All other authors declare that they have no conflicts of interest.
References
-
- Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Addington JA, Cannon TD. North American Prodrome Longitudinal Study (NAPLS 2): Overview and recruitment. Schizophr Res. 2012;142:77–82. doi: 10.1016/j.schres.2012.09.012. - DOI - PMC - PubMed
-
- Brodey BB, Goodman SH, Baldasaro RE, Brooks-DeWeese A, Wilson ME, Brodey ISB, Doyle MN. Development of the Perinatal Depression Inventory (PDI)-14 using item response theory: A comparison of the BDI-II, EPDS, PDI, and PHQ-9. Arch Womens Ment Health. 2016;19:307–316. doi: 10.1007/s00737-015-0553-9. - DOI - PMC - PubMed
-
- Cella D, Yount S, Rothrock N, Gershon R, Cook K, Reeve B, Ader D, Fries JF, Bruce B, Rose M, PROMIS Cooperative Group The Patient-Reported Outcomes Measurement Information System (PROMIS): Progress of an NIH Roadmap cooperative group during its first two years. Medical Care. 2007;45(5):S3–S11. doi: 10.1097/01.mlr.0000258615.42478.55. - DOI - PMC - PubMed
-
- Comparelli A, De Carolis A, Emili E, Rigucci S, Falcone I, Corigliano V, Curto M, Trovini G, Dehning J, Kotzalidis GD, Girardi P. Basic symptoms and psychotic symptoms: their relationships in the at risk mental states, first episode and multi-episode schizophrenia. Compr Psychiatry. 2014;55:785–791. doi: 10.1016/j.comppsych.2014.01.006. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials